Patients first. Gastrointestinal oncologist @TU_Muenchen - Precision medicine and rare cancers enthusiast.
Munich, Germany
Joined January 2011
- Tweets37
- Following432
- Followers194
- Likes1.3K
Sebastian Lange retweeted
I am disappointed at a system where for a 85 year old man who has progressed on 3 lines of therapy but lives alone, I can easily prescribe 4th line of treatment at the click of a button that costs the system 15K a month, but can’t arrange for a social support worker who can cook him food, bathe him, buy him groceries etc. that’d hardly cost the system 1K a month!
Sebastian Lange retweeted
What an immense pleasure & pleasant surprise to bump into @marklewismd here at @myESMO @ESMOGI24 discussing #PrecisionMedicine in GI #cancers in front of poster #236 by @SebLange - only missing @heinrich_kat to complete the crew.
Sebastian Lange retweeted
Heading home (to Hamburg) after 3 fantastic days in Freiburg.
While we realized that we are really bad at staying in time - pushing #PrecisionOncology forward seems doable w such amazing friends & colleagues 🫶
@SebLange @graokane @SaborowskiAnna @QuanteMichael @FilippoPietran4 – at Freiburg im Breisgau, Germany
Prof. @SonjaLoges plädiert für neue GBA-Prozesse - PatientInnen mit seltenen molekularen Subtypen sind nicht adäquat abgebildet. Danke für das klare Statement! #DKK2022
Sebastian Lange retweeted
It’s official: The @LMU_Uniklinikum @TU_Muenchen Comprehensive #Cancer Center Munich will join the European Reference Network for Rare Adult Cancers @ERN_EURACAN
We are excited to join forces w our European colleagues to improve diagnostic & therapeutic options for our patients.
IDH2i in solid cancers? We have a patient w/ iCCA and IDH2 R172W (no other drivers); PD on Gem/Cis starting on nal-IRI/5-Fu. Sensible to talk about Enasidenib if PD on 2L? There seems to be no data for solid cancers..
@pashtoonkasi @Dr_R_Kurzrock @BenWestphalen
68yo pt. with junctional Adeno-Ca and partly neuroend. differentiation. Progress on FLOT at an OSH. Sequencing: MSS, TMB low, P53 mut., SMARCA4 mut., CCNE1 amp. However: MET Exon14 skipping (!) - literature is unhelpful - any treatment experiences for this outside of NSCLC?
Excited to share our work on the analysis of mouse cancer genomes/exomes. Protocol: em.rdcu.be/wf/click?upn=lMZy…. Code including a ready-to-run container: github.com/roland-rad-lab/Mo….
Our #FreeAccessProtocol this week details standardized #computational pipelines for analyzing #cancer genome #sequencingdata from #mice go.nature.com/36H2pqJ
Looking forward to discussing and presenting our Molecular Tumorboard, which has been growing exponentially in the last two years, today @TU_Muenchen. Excited to be joined by @BenWestphalen from @LMU_Muenchen! #CCCMünchen - bit.ly/33pDp4L